The aim of this study was to examine the effects of immobilizing rhPDGF-BB plus rhBMP-2 on heparinized-Ti implants on in vivo osseointegration and vertical bone regeneration at alveolar ridges. Successful immobilizations of rhPDGF-BB and/or rhBMP-2 onto heparinized-Ti (Hepa/Ti) were confirmed by in vitro analysis, and both growth factors were found to be sustained release. To evaluate bone regeneration, rhPDGF-BB, and/or rhBMP-2-immobilized Hepa/Ti implants were inserted into beagle dogs; implant stability quotients (ISQ), bone mineral densities, bone volumes, osseointegration, and bone formation were assessed by micro CT and histometrically. In vivo study showed that the osseointegration and bone formation were greater in the rhPDGF-BB/rhBMP-2-immobilized Hepa/Ti group than in the rhPDGF-BB-immobilized Hepa/Ti group. The rhPDGF-BB/rhBMP-2 immobilized Hepa/Ti group also showed better implant stability and greater bone volume around defect areas and intra-thread bone density (ITBD) than the rhBMP-2-immobilized Hepa/Ti group. However, no significant differences were observed between these two groups. Through these results, we conclude rhBMP-2 immobilized, heparin-grafted implants appear to offer a suitable delivery system that enhances new bone formation in defect areas around implants. However, we failed to observe the synergetic effects for the rhBMP-2 and rhPDGF-BB combination.
Introduction
Dental implants have been generally used as credible and secure treatments for the restoration of function and aesthetics of edentulous patients [1] . However, patients who have insufficient bone quality and quantity, or poor healing and regenerative capacities have been reported to experience unfavorable results after implant treatment [2] . To improve the success rate of these patients, it is important to increase the initial fixation of implant fixtures and to shorten the time required for the upper prosthesis to connect [3] . Recently, developments have focused on biomimetic treatment techniques based on applying biomolecules, such as bone morphogenetic protein (BMP) or platelet-derived growth factor (PDGF), to implant surfaces to address these problems [4] [5] [6] .
Surface Modification of Titanium (Ti) with Heparin-Dopamine (Hepa-DOPA) and rhPDGF-BB and/or rhBMP-2
In order to immobilize rhPDGF-BB and/or rhBMP-2, Ti surfaces were modified with heparin-dopamine (Hepa-DOPA). Ti discs were placed in 10 mL Tris·HCl buffer (pH 8.0, 10 mM) containing 2 mg/mL Hepa-DOPA in the darkroom for 24 h. The Hepa-DOPA modified Ti disc was rinsed with distilled water (DW) and dried under nitrogen. Hepa-DOPA modified Ti is hereafter referred to as Heparinized-Ti (Hepa/Ti). To immobilize both rhPDGF-BB and rhBMP-2 on the surface of Hepa/Ti, a Hepa/Ti disc was immersed in MES buffer solution (pH 5.6, 0.1 M), and then rhPDGF-BB (50 ng/mL) and rhBMP-2 (50 ng/mL) were added. The reaction was allowed to proceed for 24 h at room temperature (RT), and then the disc was rinsed with DW and dried. rhPDGF-BB and rhBMP-2 immobilized on Hepa/Ti disc are hereafter referred to as PDGF/BMP/Hepa/Ti disc. rhPDGF-BB (100 ng/mL) or rhBMP-2 (100 ng/mL) modified Hepa/Ti disc were also fabricated using the same method. rhPDGF-BB or rhBMP-2 immobilized on Hepa/Ti disc are hereafter referred to as PDGF/Hepa/Ti or BMP/Hepa/Ti disc, respectively.
2.3. Characterization of Ti, Hepa/Ti, PDGF/Hepa/Ti, BMP/Hepa/Ti, and PDGF/BMP/Hepa/Ti Substrates
Scanning Electron Microscope (SEM) Image
The surfaces of Ti, Hepa/Ti, PDGF/Hepa/Ti, BMP/Hepa/Ti, and PDGF/BMP/Hepa/Ti disc were observed by scanning electron microscopy (SEM; S-2300, Hitachi, Tokyo, Japan). Samples were coated with gold using a sputter coater (Eiko IB, Eiko Engineering, Tokyo, Japan) and SEM was performed at 3 kV.
X-ray Photoelectron Spectroscopy (XPS)
The surface chemical compositions of Ti, Hepa/Ti, PDGF/Hepa/Ti, BMP/Hepa/Ti, and PDGF/BMP/Hepa/Ti disc were investigated by X-ray photoelectron spectroscopy (XPS; K-Alpha spectrometer; Thermo Electron, Rockford, IL, USA). Amounts of heparin immobilized onto Ti were measuredusing toluidine blue. Hepa/Ti disc was immersed in 1 mL PBS buffer (pH 7.4) containing 1 mL 0.005% toluidine blue, gently shaken for 30 min, and 2 mL of hexane was added. After removing the disc, absorbance of the aqueous phase was measured by a Flash Multimode Reader (Varioskan™, Thermo Scientific, Waltham, MA, USA) at 620 nm. The amount of heparin immobilized onto disc were calculated using a calibration curve prepare using different concentrations of heparin.
In Vitro rhPDGF-BB and rhBMP-2 Release
To determine the releases of rhPDGF-BB and rhBMP-2 from PDGF/Hepa/Ti, BMP/Hepa/Ti, and PDGF/BMP/Hepa/Ti, a prepared disc was placed in a 15 mL conical tube (Falcon, North Haledon, NJ, USA) containing PBS buffer (pH 7.4) at 37 • C with 100 rpm. At predetermined times of 1 h, 3, 6, and 10 h, and 1, 3, 5, 7, 10, 14, 21, and 28 days, supernatants were collected and buffer was replenished with an equal volume of fresh PBS. Amounts of rhPDGF-BB and rhBMP-2 released were determined using an enzyme-linked immunosorbent assay kit (ELISA), according to the manufacturer's instruction using a Varioskan Flash Multimode Reader (Thermo Fisher Scientific, Waltham, MA, USA) at 450 nm.
In Vitro Cell Study

Alkaline Phosphatase (ALP) Activity
To confirm the effects of immobilized rhPDBF-BB, rhBMP-2, or rhPDGF-BB/rhBMP-2 on osteogenic differentiation, we evaluated the ALP activities and calcium contents, as early and late differentiation of MG-63 osteoblast-like cells, were evaluated, respectively. ALP activities were measured after culture for 3, 7, or 10 days. In brief, cells (1 × 10 5 cells/mL) were seeded on the surfaces of each Ti disc (n = 5). At predesignated times, cells and Ti sample were washed with PBS. Then, RIPA buffer (1×) containing protease and phosphatase inhibitor was added to cells. Cells were then lysed with RIPA (1×) buffer and centrifuged at 13,500 rpm for 1 min to remove cell debris. P-nitrophenyl phosphate solution was then added to supernatants and incubated for 30 min at 37 • C and 1 N NaOH was added to stop reactions. Optical densities of ALP were determined using a Flash Multimode Reader at 405 nm.
Calcium Contents
To determine the calcium contents of MG-63 cells, cells were seeded at a density of 1 × 10 5 cells/mL on the surfaces of each Ti disc (n = 5) and cultured for 7 or 21 days. Ti discs were then rinsed with PBS, and treated with 0.5 N HCl for 24 h, the Ti discs containing cells were performed by centrifugation at 13,500 rpm for 1 min. Calcium contents were assessed by a QuantiChrom Calcium Assay Kit (DICA-500, BioAssay Systems, Hayward, CA, USA) using calcium chloride as a standard and a Flash Multimode Reader at 612 nm.
Gene Expressions
To assess the osteogenic differentiation effects of different substrates, gene expressions of osteogenic differentiation markers, that is, osteocalcin (OCN) and osteopontin (OPN), were investigated by real-time PCR. Cells were seeded at 1 × 10 5 cells/mL on Ti, PDGF/Hepa/Ti, BMP/Hepa/Ti, and PDGF/BMP/Hepa/Ti, and cultured for 7 or 21 days (n = 5). RNA was extracted using the RNeasy Plus Mini Kit (Qiagen, Valencia, CA, USA). 1 µg of total RNA was reverse transcribed into cDNA using AccuPower RT PreMix (Bioneer, Daejeon, Korea), according to the manufacturer's protocol. Primer sequences of target genes were as follows: OCN (F) 5 -TTG GTG CAC ACC TAG CAG AC-3 , (R) 5 -ACC TTA TTG CCC TCC TGC TT-3 ; and OPN (F) 5 -GAG GGC TTG GTT GTC AGC-3 , (R) 5 -CAA TTC TCA TGG TAG TGA GTT TTC C-3 . PCR amplification and detection were performed using an ABI7300 Real-Time Thermal Cycler (Applied Biosystems, Foster, CA, USA).
In Vivo Animal Study
Fabrication of Implants
Forty implants (Ø 4.0 × H 8.0; Cowellmedi Co., Busan, Korea) were prepared for animal study. All of the the treated implants were fabricated by pure titanium (grade 4), and had microthreads on one end and broader threads on the other. Implant surfaces were anodized (Cowellmedi Co., Busan, Korea), and anodized implants were used as controls (Ti group), the experimental groups were as follows; the heparinized implant group (the Hepa/Ti group), the rhPDGF-BB (0.75 mg/mL) [33] immobilized implant group (the PDGF/Hepa/Ti group), the rhBMP-2 (0.75 mg/mL) immobilized implant group (BMP/Hepa/Ti group), and the rhPDGF-BB (0.75 mg/mL) plus rhBMP-2 (0.75 mg/mL) [34, 35] immobilized implant group (PDGF/BMP/Hepa/Ti group). Eight implants were allocated to each group (a total of 40). To apply rhBMP-2/rhPDGF-BB coating, each implant was placed h in the protein solution for 12 (0.75 mg/mL for rhBMP-2, 0.75 mg/mL for rhPDGF-BB) up to its microthreads, and then freeze dried under sterile conditions (freeze dried at −40 • C, and then vacuum dried at ≤20 • C).
This study was carried out with the approval from the Ethics Committee on Animal Experimentation of Chun Nam University (CNU IACUC-TB-2010-10). Five three-year-old beagle dogs of weight 13-15 kg were used for this study. Animals were given two-weeks to acclimatize, fed a soft-dog food diet, and had free access to water.
Surgical Procedures
At first surgery, premolars and first molars of upper and lower jaws were extracted. Animals were pre-anaesthetized with atropine sulfate induction (0.05 mg/kg IM; Dai Han Pharm Co., Seoul, Korea) and maintained on isoflurane (Choongwae Co., Seoul, Korea) gas anesthesia. Lidocaine (1 mL; Yu-Han Co., Gunpo, Korea) containing 1:100,000 epinephrine was infiltrated into mucosae at surgical sites. The upper, lower premolars, and first molars were separated into mesial and distal roots. Care was taken to preserve the lateral, lingual, and buccal walls of alveolar sockets. Teeth were extracted carefully, and extraction sites were sutured with nylon silk (4-0, Mersilk, Ethicon Co., Livingston, UK) to enhance healing. The extraction sites were allowed to heal for two months.
Implant surgery was performed when extraction sockets had completely healed. The anesthesias (local and general) were performed, as described for first surgery. The implants of each groups were implanted at edentulous mandibular alveolar ridge. Briefly, each alveolar ridge was trimmed bỹ 1.5 mm to create a flat ridge before implant insertion, the buccal open defect model that had 2.5 mm depth was formed. This model was not buccal bone, and there was mesial-lingual-distal 1 mm defect area around 2.5 mm upper portion of implant ( Figure 1a ). Implants (control (Ti) group, Hepa/Ti group, PDGF/Hepa/Ti group, BMP/Hepa/Ti group, and PDGF/BMP/Hepa/Ti group) were installed randomly on right and left mandibular alveolar ridges (8 implants per dog). To place implants at the same position on both sides, exposed bone was marked at implant placement sites using a ruler. 5 mm of implant was placed within the reduced alveolar ridge to the reference notch level (shown on the implant), which resulted in a 2.5 mm peri-implant buccal open defects (Figure 1b,c) . Each implant was covered with cover-screw. Mucoperiosteal flaps were advanced, adapted, and sutured leaving the implants submerged.
Implant surgery was performed when extraction sockets had completely healed. The anesthesias (local and general) were performed, as described for first surgery. The implants of each groups were implanted at edentulous mandibular alveolar ridge. Briefly, each alveolar ridge was trimmed by ~1.5 mm to create a flat ridge before implant insertion, the buccal open defect model that had 2.5 mm depth was formed. This model was not buccal bone, and there was mesial-lingual-distal 1 mm defect area around 2.5 mm upper portion of implant (Figure 1a) . Implants (control (Ti) group, Hepa/Ti group, PDGF/Hepa/Ti group, BMP/Hepa/Ti group, and PDGF/BMP/Hepa/Ti group) were installed randomly on right and left mandibular alveolar ridges (8 implants per dog). To place implants at the same position on both sides, exposed bone was marked at implant placement sites using a ruler. 5 mm of implant was placed within the reduced alveolar ridge to the reference notch level (shown on the implant), which resulted in a 2.5 mm peri-implant buccal open defects (Figure 1b,c) . Each implant was covered with cover-screw. Mucoperiosteal flaps were advanced, adapted, and sutured leaving the implants submerged. A broad spectrum antibiotic (penicillin G with was administered immediately after implant placement and again 48 h later by intramuscular injection (1 mL/5 kg). To control the plaque, Teeth were washed out with 2% chlorhexidine gluconate every day until study completion. Observations of experimental sites with regards to mucosal health, edema, maintenance of suture closure, and tissue infection or necrosis were made daily until suture removal. Suture materials were removed one week after implant placement. Experimantal animals were given a soft diet for two weeks, followed by a conventional regular diet. The animals were anesthetized and euthanized at eight weeks after implant placement by intravenous injection of concentrated sodium pentobarbital (Euthasol, Delmarva Laboratories Inc., Midlothian, VA, USA). Following euthanasia, block sections including implants, alveolar bone, and surrounding mucosa were collected. A broad spectrum antibiotic (penicillin G with was administered immediately after implant placement and again 48 h later by intramuscular injection (1 mL/5 kg). To control the plaque, Teeth were washed out with 2% chlorhexidine gluconate every day until study completion. Observations of experimental sites with regards to mucosal health, edema, maintenance of suture closure, and tissue infection or necrosis were made daily until suture removal. Suture materials were removed one week after implant placement. Experimantal animals were given a soft diet for two weeks, followed by a conventional regular diet. The animals were anesthetized and euthanized at eight weeks after implant placement by intravenous injection of concentrated sodium pentobarbital (Euthasol, Delmarva Laboratories Inc., Midlothian, VA, USA). Following euthanasia, block sections including implants, alveolar bone, and surrounding mucosa were collected.
Measurment of Implant Stability
Implant stability quotient (ISQ) values were measured to evaluate stability at the time of placement. ISQ values of all the implants placed in mandibles were measured immediately and at week eight after second surgery using Osstell Mentor ® (Integtration Diagnostic Ltd., Göteborg, Sweden). ISQ values were measured five times for each implant, and mean and standard deviations (SDs) were calculated after excluding minimum and maximum values.
Micro Computed Tomography (µCT)
The collected samples were fixed in phosphate-buffered formaldehyde (pH 7.4, 0.1 M PBS) and dehydratied in ethanol 70%. Three dimensional (3D) µCT images were obtained to determine bone mineral densities and bone volumes surrounding implants in defect areas. Specimens were wrapped using Parafilm M ® (Pechiney Plastic Packaging, Chicago, IL, USA) to prevent dry during scanning, and scanned at 130 kV and 60 µA with a resolution of 12µm pixels using a bromine filter (0.25 mm) (Skyscan-1173 Skyscan ® , Kontich, Belgium). In addition, calibration rods of standard bone mineral densities were also scanned. Cone-beam reconstruction (version 2.15, Skyscan ® , Kontich, Belgium) was performed, and all scan and reconstruction parameters that were applied were identical for all the specimens and calibration rods. The collected data were analyzed by a CT analyser (version 1.4, Skyscan ® , Kontich, Belgium). The region of interest (ROI) was defined as annular region of thickness 1 mm surrounding a defect area in the marginal peri-implant from the first microthread to the last microthread. Bone volumes (mm 3 ) were measured in this region ( Figure 2 ) and were expressed as percentages of the total ROI volumes (mm 3 ).
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The collected samples were fixed in phosphate-buffered formaldehyde (pH 7.4, 0.1M PBS) and dehydratied in ethanol 70%. Three dimensional (3D) μCT images were obtained to determine bone mineral densities and bone volumes surrounding implants in defect areas. Specimens were wrapped using Parafilm M ® (Pechiney Plastic Packaging, Chicago, IL, USA) to prevent dry during scanning, and scanned at 130 kV and 60 μA with a resolution of 12μm pixels using a bromine filter (0.25 mm) (Skyscan-1173 Skyscan ® , Kontich, Belgium). In addition, calibration rods of standard bone mineral densities were also scanned. Cone-beam reconstruction (version 2.15, Skyscan ® , Kontich, Belgium) was performed, and all scan and reconstruction parameters that were applied were identical for all the specimens and calibration rods. The collected data were analyzed by a CT analyser (version 1.4, Skyscan ® , Kontich, Belgium). The region of interest (ROI) was defined as annular region of thickness 1 mm surrounding a defect area in the marginal peri-implant from the first microthread to the last microthread. Bone volumes (mm 3 ) were measured in this region ( Figure 2 ) and were expressed as percentages of the total ROI volumes (mm 3 ). Region of interest (ROI) was defined as an annular area of thickness 1 mm surrounding the defect area (red circle) in the marginal portion of the peri-implant from the first microthread to the last microthread. Bone volumes were measured in this ROI.
Histologic and Histometric Analysis
The harvested specimens were imsersed in neutral buffered formalin (Sigma Aldrich, St Louis, MO, USA), fixed for two weeks, and dehydrated in ascending concentrations of ethanol (70%, 80%, 90%, and 100%), and embedded in Technovit 7200 VLC resin (Heraeus KULZER, South Bend, IN, USA). Embedded specimen blocks were sectioned longitudinally from the center of implant using an Region of interest (ROI) was defined as an annular area of thickness 1 mm surrounding the defect area (red circle) in the marginal portion of the peri-implant from the first microthread to the last microthread. Bone volumes were measured in this ROI.
The harvested specimens were imsersed in neutral buffered formalin (Sigma Aldrich, St Louis, MO, USA), fixed for two weeks, and dehydrated in ascending concentrations of ethanol (70%, 80%, 90%, and 100%), and embedded in Technovit 7200 VLC resin (Heraeus KULZER, South Bend, IN, USA). Embedded specimen blocks were sectioned longitudinally from the center of implant using an diamond cutter (KULZER EXAKT 300, EXAKT, Norderstedt, Germany). The final slides (30 µm) were prepared from initial 400 µm slides by grinding sections using an grinding machine (KULZER EXAKT 400CS, EXAKT, Norderstedt, Germany). Hematoxylin-eosin staining was perfomed, and images were captured by computer connected to light microscope (Olympus BX, Olympus, Tokyo, Japan) attached to a CCD camera (Polaroid DMC2 digital Microscope camera (Polaroid Corporation, Cambridge, MA, USA). All assessments were made by one skilled investigator using SPOT Software (Ver. 4.0, Diagnostic Instrument, Inc., Sterling Heights, MI, USA).
The following parameters [36] were evaluated:
• Bone growth height in buccal defect areas (BG, mm): The thickness of bone that grew upward from the implant from the reference point on the buccal defect site on the alveolar ridge.
• Bone to implant contact in microthreads (microBIC, %): The bone to implant contact ratio was measured in buccal and lingual defect areas where the bone grew along the implant from the implantation reference point on the alveolar ridge.
• Bone to implant contact in macrothreads (macroBIC, %): The bone to implant contact ratio was measured in existing bone where the implant was implanted.
• Intra-thread bone density in macrothreads (ITBD, %): Intra-thread bone density was measured in the existing bone where the implant was placed.
After measuring the percentage of bone to implant contact (BIC, %), the ratio of bone formation area on intra-threads of implant to overall threads was calculated to determine intra-thread bone density (ITBD, %). Height of newly formed marginal bone by implants was measured. images of specimens were captured at a magnification of ×12.5 and ×40. For the histometric analysis, a magnification of ×40 was used.
Statistical Analysis
All of the analyses were performed using statistical program (SPSS ver. 21.0). Mean and SDs of ISQ values and of BIC and ITBD values were calculated for each group. Comparisons of ISQ values between the experimental and control groups were made using the Mann-Whitney U test. The Shapiro-Wilk test was used to test the normalities of distributions, and then one-way ANOVA was used to compare group BICs, ITBDs, and bone growths. Post hoc testing was performed using Bonferroni's test using a significance level of 95%.
Results
Characterization of Ti and Modified Ti Morpholgies
Scanning Electron Microscopy (SEM)
As shown in Figure 3 , the surface morphologies of Ti, Hepa/Ti, PDGF/Hepa/Ti, BMP/Hepa/Ti, and PDGF/BMP/Hepa/Ti discs were investigated using SEM. Ti modified with rhHepa-DOPA, rhPDGF-BB, rhBMP-2, or rhPDGF-BB/rhBMP-2 had surface morphologies similar to Ti alone. These results indicate that the surfaces of Ti modified by small molecules, such as, Hepa-DOPA, rhPDGF-BB, rhBMP-2, or rhPDGF-BB/rhBMP-2 cannot be differentiated by SEM. 
X-ray Photoelectron Spectroscopy (XPS)
The surface chemical compositions of all Ti substrates determined by XPS are shown in Table 1 . After anchoring Hepa-DOPA on the surface of Ti, C1s, and N1s peaks increased to compare with Ti alone. After immobilizing rhPDGF-BB and/or rhBMP-2 on the surface of Hepa/Ti disc, the N1s peak was increased and the S2p peak decreased versus Hepa/Ti. The amount of heparin anchored onto the Ti surface was 1.62 ± 0.32 μg/disc. 
In Vitro rhPDGF-BB and rhBMP-2 Releases
The release behaviors of rhPDGF-BB or rhBMP-2 from PDGF/Hepa/Ti, BMP/Hepa/Ti, and PDGF/BMP/Hepa/Ti are shown in Figure 4 , respectively. The amounts of rhPDGF-BB released from PDGF/Hepa/Ti and PDGF/BMP/Hepa/Ti discs were 25.20 ± 6.48 ng and 15.56 ± 4.55 ng after 1 day, respectively. Over 28 days, the amounts of rhPDGF-BB released were 66.69 ± 5.81 ng for PDGF/Hepa/Ti and 34.52 ± 4.55 ng for PDGF/BMP/Hepa/Ti. In addition, on day 1, the amounts of rhBMP-2 that is released from BMP/Hepa/Ti and PDGF/BMP/Hepa/Ti were 27.46 ± 6.71 ng and 16.56 ± 4.48 ng, respectively. Over the 28-day period, the amount of rhBMP-2 released was 69.85 ± 7.43 ng for BMP/Hepa/Ti and 37.52 ± 4.26 ng for PDGF/BMP/Hepa/Ti. 
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In Vitro Cell Study
3.3.1. ALP Activity ALP activities of MG-63 cells seeded on the surface of Ti, PDGF/Hepa/Ti, BMP/Hepa/Ti, and PDGF/BMP/Hepa/Ti discs were confirmed after 3, 7, and 10 days of culture (Figure 5a ). On day 3, the ALP activities of cells cultured on PDGF/Hepa/Ti, BMP/Hepa/Ti, and PDGF/BMP/Hepa/Ti were higher than that of cells cultured on Ti. On days 7 and 10, the ALP activities of cells that are grown on PDGF/Hepa/Ti, BMP/Hepa/Ti, and PDGF/BMP/Hepa/Ti differed significantly from those grown on Ti alone. On days 7 and 10, the ALP activity of cells cultivated on BMP/Hepa/Ti was significantly higher than that of those cultyivated on PDGF/Hepa/Ti or PDGF/BMP/Hepa/Ti.
Calcium Contents
The calcium contents of MG-63 cells cultured on Ti, PDGF/Hepa/Ti, BMP/Hepa/Ti, and PDGF/BMP/Hepa/Ti discs for 7 and 21 days are shown in Figure 4 . The calcium contents of cells cultivated on PDGF/Hepa/Ti, BMP/Hepa/Ti, and PDGF/BMP/Hepa/Ti were significantly greater than that those that were grown on Ti alone on days 7 and 21. Moreover, the calcium contents of cells grown on BMP/Hepa/Ti and PDGF/Hepa/Ti and on BMP/Hepa/Ti and PDGF/BMP/Hepa/Ti differed significantly. 
The calcium contents of MG-63 cells cultured on Ti, PDGF/Hepa/Ti, BMP/Hepa/Ti, and PDGF/BMP/Hepa/Ti discs for 7 and 21 days are shown in Figure 4 . The calcium contents of cells cultivated on PDGF/Hepa/Ti, BMP/Hepa/Ti, and PDGF/BMP/Hepa/Ti were significantly greater than that those that were grown on Ti alone on days 7 and 21. Moreover, the calcium contents of cells grown on BMP/Hepa/Ti and PDGF/Hepa/Ti and on BMP/Hepa/Ti and PDGF/BMP/Hepa/Ti differed significantly.
Gene Expressions
After 7 and 21 days of culture, the mRNA expression levels of OCN and OPN in cells grown on Ti disc or on Ti modified with rhPDGF-BB and/or rhBMP-2 were determined by real-time PCR (Figure 6 ). mRNA expression levels of OCN and OPN in cells cultured on BMP/Hepa/Ti or PDGF/BMP/Hepa/Ti were markedly higher than in those cultured on Ti alone at day 7. In addition, OCN and OPN expressions in cells cultivated on PDGF/Hepa/Ti were greater than in those cultivated on Ti alone at day 7, but not significantly so. On day 21, the expression levels of OCN and OPN in cells that are grown on Hepa/Ti immobilized with rhPDGF-BB and/or rhBMP-2 and Ti alone were significantly different, as were OCN and OPN expressions in cells cultivated on BMP/Hepa/Ti and PDGF/Hepa/Ti or PDGF/BMP/Hepa/Ti discs.
After 7 and 21 days of culture, the mRNA expression levels of OCN and OPN in cells grown on Ti disc or on Ti modified with rhPDGF-BB and/or rhBMP-2 were determined by real-time PCR (Figure 6 ). mRNA expression levels of OCN and OPN in cells cultured on BMP/Hepa/Ti or PDGF/BMP/Hepa/Ti were markedly higher than in those cultured on Ti alone at day 7. In addition, OCN and OPN expressions in cells cultivated on PDGF/Hepa/Ti were greater than in those cultivated on Ti alone at day 7, but not significantly so. On day 21, the expression levels of OCN and OPN in cells that are grown on Hepa/Ti immobilized with rhPDGF-BB and/or rhBMP-2 and Ti alone were significantly different, as were OCN and OPN expressions in cells cultivated on BMP/Hepa/Ti and PDGF/Hepa/Ti or PDGF/BMP/Hepa/Ti discs. 
In Vivo Animal Study
Clinical Findings
All of the experimental animals survived during the healing procedure, and there was no observation of infection or inflammation at surgical sites. Samples of 40 implants were collected without any issue for in vivo μCT and Histomorphometric analysis.
Stability Evaluation
Immediately after implantation, the ISQ values in all of the experimental groups were higher than in control group, but differences were not statistically significant. At eight weeks after surgery, ISQ values were higher than at baseline in the experimental groups, whereas in the control group, they were lower or similar than baseline values. ISQ increases were significantly greater in the experimental groups than in the control group (p < 0.05) ( Table 2) . But, no difference was observed between the groups (p > 0.05). 
In Vivo Animal Study
Clinical Findings
All of the experimental animals survived during the healing procedure, and there was no observation of infection or inflammation at surgical sites. Samples of 40 implants were collected without any issue for in vivo µCT and Histomorphometric analysis.
Stability Evaluation
Immediately after implantation, the ISQ values in all of the experimental groups were higher than in control group, but differences were not statistically significant. At eight weeks after surgery, ISQ values were higher than at baseline in the experimental groups, whereas in the control group, they were lower or similar than baseline values. ISQ increases were significantly greater in the experimental groups than in the control group (p < 0.05) ( Table 2) . But, no difference was observed between the groups (p > 0.05). (Figure 7 ; n = 8). Bone volumes in the BMP/Hepa/Ti and PDGF/BMP/Hepa/Ti groups were significantly higher than in the other groups (p < 0.05). But, there was no significant difference between the BMP/Hepa/Ti and PDGF/BMP/Hepa/Ti groups (p > 0.05). 
Micro Computed Tomography (μCT)
Mean bone volume (%) in the control group was 18.19 ± 4.39% and in the Hepa/Ti, PDGF/Hepa/Ti, BMP/Hepa/Ti, and PDGF/BMP/Hepa/Ti groups mean bone volumes were 13.05 ± 5.15, 21.29 ± 9.56, 40.95 ± 9.07, and 43.73 ± 6.75%, respectively ( Figure 7 ; n = 8). Bone volumes in the BMP/Hepa/Ti and PDGF/BMP/Hepa/Ti groups were significantly higher than in the other groups (p < 0.05). But, there was no significant difference between the BMP/Hepa/Ti and PDGF/BMP/Hepa/Ti groups (p > 0.05). 
Histomorphometric Analysis
Jaw quadrants in the BMP/Hepa/Ti and PDGF/BMP/Hepa/Ti groups exhibited bone formation approaching microthreads and bone remodeling around implants (Figure 8 ). There was about 1.1 mm more bone gain in the BMP/Hepa/Ti and PDGF/BMP/Hepa/Ti groups than in the control group (p < 0.05). In the control and heparin groups, vertical bone loss was observed in buccal defect areas. The control, heparin, and PDGF groups showed failure of osseointegration in lingual regions observed a 1 mm gap between fixture and bone ( Figure 9 ). The microBIC values of the BMP/Hepa/Ti and PDGF/BMP/Hepa/Ti groups were significantly greater than those of the other groups (p < 0.05), but no significant difference was observed between the BMP/Hepa/Ti and PDGF/BMP/Hepa/Ti groups (p > 0.05). The BMP/Hepa/Ti and PDGF/BMP/Hepa/Ti groups showed successful osseointegration in lingual portions (Figure 10 ). Mean group percentages (±SD) of BIC and ITBD within macrothreads eight weeks after surgery were not significantly different (p > 0.05) ( Table 3 ). 
Jaw quadrants in the BMP/Hepa/Ti and PDGF/BMP/Hepa/Ti groups exhibited bone formation approaching microthreads and bone remodeling around implants (Figure 8 ). There was about 1.1 mm more bone gain in the BMP/Hepa/Ti and PDGF/BMP/Hepa/Ti groups than in the control group (p < 0.05). In the control and heparin groups, vertical bone loss was observed in buccal defect areas. The control, heparin, and PDGF groups showed failure of osseointegration in lingual regions observed a 1 mm gap between fixture and bone ( Figure 9 ). The microBIC values of the BMP/Hepa/Ti and PDGF/BMP/Hepa/Ti groups were significantly greater than those of the other groups (p < 0.05), but no significant difference was observed between the BMP/Hepa/Ti and PDGF/BMP/Hepa/Ti groups (p > 0.05). The BMP/Hepa/Ti and PDGF/BMP/Hepa/Ti groups showed successful osseointegration in lingual portions (Figure 10 ). Mean group percentages (±SD) of BIC and ITBD within macrothreads eight weeks after surgery were not significantly different (p > 0.05) ( Table 3 ). Bone growth height in buccal defect area (mm); microBIC: Bone to implant contact in the microthreads (%); macroBIC: Bone to implant contact in macrothreads (existing bone area around implant, %); ITBD: Intra-thread bone density in macrothreads (existing bone area around implant, %); a,b : Means with the same superscripts in same columns were not significantly different; p values were obtained by ANOVA; *p < 0.05.
Discussion
Many studies have been conducted on implant surfaces treated with growth factors like BMP-2, to increase vertical and horizontal bone regeneration without the use of additional bone grafts or barrier membranes [37, 38] . Although BMP-2 is one of the effective growth factors, rapid release at an early stage and rapid diffusion into body fluids has limited its clinical applications [39, 40] . In order to overcome these problems, the present study was undertaken on a heparin-based release system to provide the sustained and local release of BMP-2 [30, 41, 42] . Since titanium has good mechanical properties, corrosion resistance, and biocompatibility without biological activity, it is generally used as an implant material [43] . Due to its inertness in vivo, physical adsorption or chemical coatings are 
Many studies have been conducted on implant surfaces treated with growth factors like BMP-2, to increase vertical and horizontal bone regeneration without the use of additional bone grafts or barrier membranes [37, 38] . Although BMP-2 is one of the effective growth factors, rapid release at an early stage and rapid diffusion into body fluids has limited its clinical applications [39, 40] . In order to overcome these problems, the present study was undertaken on a heparin-based release system to provide the sustained and local release of BMP-2 [30, 41, 42] . Since titanium has good mechanical properties, corrosion resistance, and biocompatibility without biological activity, it is generally used as an implant material [43] . Due to its inertness in vivo, physical adsorption or chemical coatings are required to enable biomolecules to adhere to titanium surfaces [44] . However, the chemical substances used for this purpose, such as, APTES, EDAC, and NHS, are harmful to the human body [45] . In this study, titanium was coated with heparin using a dopamine surface modification technique, which has been reported to be biocompatible in in vivo toxicity studies [46] . Dopamine is a small molecule substance that possesses catechol and amine functional groups [47] . The catechol component bonds to titanium oxide surfaces and provides an amine group that can bind heparin [48, 49] .
It has been reported that combinations of different growth factors produce synergistic effects that promote the complex cellular activities that occur during bone regeneration and osseointegration [33, 50, 51] . However, most studies are limited to cell experiments, the studies reproducing the clinical situation in large animals are rare. Therefore, in the present study, rhBMP-2 and rhPDGF-BB immobilized on Ti surfaces modified with Hepa-DOPA were utilized to establish an effective growth factor delivery system to ensure sustained factor release in appropriate amounts over sufficient time in beagle mandible model. The concentration of rhBMP-2 that is used in this study was set based on our previous studies, which reported 0.75 mg/mL of rhBMP-2 is effective on bone regeneration [34, 35] . In PDGF, the previous study of Choo et al. [33] reported that the appropriate concentration of PDGF was from 0.3 mg/mL up to 1 mg/mL, thus we chose 0.75 mg/mL of PDGF concentration within that range. BMP and PDGF combined groups were studied in 1:10 ratio (PDGF:BMP) in previous cell study [6] , but we intended to increase the rate of PDGF to get enhanced bone regeneration as ratio of 1:1. The results of our in vitro release experiments indicated that the inclusion of heparin achieved sustained growth factor release, although previous studies have reported a burst release pattern resulting in the release of 70%-90% over the first 6 h [52] . After 24 h, the amounts of PDFG-BB and rhBMP released from PDGF/Hepa/Ti and BMP/Hepa/Ti were approximately 38%, respectively, and the amounts of rhBMP and PDGF-BB released from PDGF/BMP/Hepa/Ti were 45%, respectively. This suggests that PDGF-BB and rhBMP-2 show similar release tendencies in the presence of other growth factors and heparin.
SEM analysis of Ti surface modified by heparin, rhPDGF-BB, or/and rhBMP-2 showed their surface morphologies were similar to that of untreated Ti. XPS showed heparin was successfully grafted on anodized Ti surfaces, as indicated by higher C and N peaks. In a previous study, successful immobilization of rhBMP-2 on surface of carboxymethyl chitosan (CMCS)-grafted Ti was attributed to the covalent bonds formation between the carboxyl groups of CMCS and the amine groups of rhBMP-2 [53] . In the present study, successful anchoring of rhBMP-2 and rhPDGF-BB to Hepa/Ti surfaces was demonstrated by further increases in N content.
ALP activity and calcium deposition as determined by in vitro studies are widely used as markers of early and late differentiation to osteoblasts, respectively [54, 55] . We measured ALP activity after culturing MG-63 for 3, 7, or 10 days and calcium deposition after 7 or 21 days. ALP activities of cells that are cultured on PDGF-BB and/or BMP/Hepa/Ti were found to be significantly higher than those of cells cultured on untreated Ti on days 7 and 10 (* p < 0.05 and ** p < 0.01). As reported in a previous study [6, 56] , our finding confirmed that rhBMP-2 and rhPDGF-BB both stimulate osteoblast differentiation. Furthermore, the calcium contents of cells cultured on PDGF-BB or/and BMP/Hepa/Ti were significantly higher than those of cells cultured on untreated Ti on days 7 and 21 (* p < 0.05 and ** p < 0.01). These results indicate that growth factor immobilized Ti substrates can stimulate matrix formation and improve osteoblast cell function. ALP activity and calcium deposition in the PDGF/BMP/Hepa/Ti group were significantly higher than in the PDGF/Hepa/Ti group, but were significantly lower than in the BMP/Hepa/Ti group. In order to investigate the gene expression levels of osteocalcin (OCN) and osteopontin (OPN), which are markers of cell differentiation, the total mRNAs of cells cultured on four Ti surfaces were extracted. On day 21, significant differences were observed between the OCN and OPN expressions of cells cultivated on BMP/Hepa/Ti and PDGF/Hepa/Ti or PDGF/BMP/Hepa/Ti.
In the result of previous cell studies [6] , PDGF-BB (5 ng/mL)/BMP-2(50 ng/mL)/Hepa/Ti (a 1:10 ratio of growth factors) was significantly higher than BMP/Hepa/Ti, whereas in this study, PDGF-BB (50 ng/mL)/BMP-2 (50 ng/mL)/Hepa/Ti (a 1:1 ratio) was significantly lower than BMP/Hepa/Ti. Furthermore, ALP, calcium deposition, and gene expression not synergistically increased by the copresence of rhPDGF-BB and rhBMP-2. These results indicate that different concentrations and ratios of PDGF-BB should be selected.
The in vivo animal study was conducted to evaluate the synergic effects of rhBMP-2 (0.75 mg/mL) when combined with rhPDGF-BB (0.75 mg/mL). A total of 40 implants of five groups (control (Ti) group, Hepa/Ti group, PDGF/Hepa/Ti group, BMP/Hepa/Ti group, and PDGF/BMP/Hepa/Ti group) were implanted without using additional implants or barrier membranes. To reproduce clinical situations, a buccal open defect model with a 2.5 mm deep peri-implant bone defect was produced in the mandibles of five beagle dogs. This model was designed with loss of buccal bone and a mesial-lingual-distal 1 mm defect area around the 2.5 mm upper portions of implants. The upper part of implants (microthread) was exposed 2.5 mm above alveolar bone and the lower part (macrothread) was implanted into cortical bone. After a healing period of eight weeks, ISQ values showed the presences of rhBMP-2 and rhPDGF-BB contributed positively to implant stability. Furthermore, ISQ increases were significantly higher in the PDGF/BMP/Hepa/Ti and BMP/Hepa/Ti groups than in the other three groups (* p < 0.05). However, there was no difference between these two experimental groups (p > 0.05). µCT analysis showed new bone volumes in the BMP/Hepa/Ti and PDGF/BMP/Hepa/Ti groups were significantly greater than in the other groups (* p < 0.05), but no significant difference was observed between these two groups (p > 0.05). Our histomorphometric analysis confirmed vertical new bone formation and osseointegration approaching microthreads around peri-implant bone defects in the BMP/Hepa/Ti and PDGF/BMP/Hepa/Ti groups, whereas osseointegration was unsuccessful in the Ti, Hepa/Ti and PDGF/Hepa/Ti groups, in which a 1 mm gap between implant fixture and bone was observed at lingual portions. microBIC values in the BMP/Hepa/Ti and PDGF/BMP/Hepa/Ti groups were significantly greater than in the other groups (* p = 0.000), but no significant difference was observed between the two (p > 0.05). Our in vivo studies were confirmed that PDGF (0.75 mg/mL)/BMP (0.75 mg/mL)/Hepa/Ti (a 1:1 growth factor) had no synergic effect. Based on these results and limitations of present study, further studies on subdivided concentrations and ratios, various implant surfaces and slow releasing systems are required to more comprehensively investigate the effects of combinations of different growth factors on osseointegration and bone regeneration.
Conclusions
Anodized Ti surfaces were successfully functionalized by surface grafting heparin and subsequently immobilizing rhBMP-2 and/or rhPDGF-BB. rhBMP-2 immobilized, heparin-grafted Ti implants were found to provide a suitable delivery system that enhanced osseointegration and bone regeneration in defect areas around implants. However, the study failed to reveal any synergetic effect resulting from the co-immobilization of rhBMP-2 and rhPDGF-BB.
